98%
921
2 minutes
20
Cancer chemoprevention is an important strategy to prevent, reverse, or suppress the development of cancer. One of the target pathways that has emerged in recent years is the Keap1-Nrf2-ARE system that regulates the protection of cells against various carcinogens and their metabolites. Increased concentrations of the redox transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2) induces the activation of antioxidant and phase 2 detoxifying genes. Nrf2 is regulated by substrate adaptor protein Kelch-like ECH-associated protein 1 (Keap1) that can target Nrf2 for ubiquitination and degradation by the proteasome. The interaction between Nrf2 and Keap1 can be disrupted at the protein-protein interface in order to increase Nrf2 activity for potential therapeutic purposes. This chapter describes a protocol for a steady-state fluorescence or Förster resonance energy transfer (FRET) assay to examine the Keap1-Nrf2 protein-protein interaction (PPI), to investigate the effects of Nrf2 mutations on Keap1 binding and finally to identify potential inhibitors of this PPI. In the assay system Keap1 is conjugated to an YFP protein at the N-terminus whereas an Nrf2-derived 16-mer peptide containing a high-affinity "ETGE" motif is conjugated to a CFP protein at the N-terminus.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/978-1-4939-3191-0_15 | DOI Listing |
Clin Drug Investig
September 2025
Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Strasse 65, 88400, Biberach an der Riss, Germany.
Background: Iclepertin is a selective inhibitor of glycine transporter 1 recently investigated as a novel treatment for cognitive impairment associated with schizophrenia. Iclepertin is a potential mild inducer of liver cytochrome P450 3A4, which metabolises ethinylestradiol and levonorgestrel, which are used in combined oral contraceptives (OCs).
Objectives: This trial investigated the potential drug interaction effect of steady-state iclepertin on the steady-state pharmacokinetics of combined OCs.
Clin Imaging
October 2025
Department of Radiology, Shiga University of Medical Science, Japan.
A vendor-neutral MR bone imaging technique based on 3D time-of-flight MR angiography with spoiled gradient recalled acquisition in the steady state (TOF-SPGR) was developed to enhance the depiction of bone and calcification/ossification. This approach is independent of scanner manufacturer and application type, enabling reduced radiation exposure by replacing or triaging further CT examinations. This article describes the optimization of scan parameters for clinical musculoskeletal protocols and explores its clinical applications with representative cases.
View Article and Find Full Text PDFFront Physiol
August 2025
Department Of Sports Medicine and Active Health Sciences, Faculty of Medicine, Charles University, Pilsen, Czechia.
Introduction: The traditional method for quantifying the kinetics of the increase in the body's consumption of oxygen ( O) during exercise transitions to steady state involves application of a mono-exponential function. Anomalies exist to question the validity of this method, as they show the initial (∼1 min) of this O response is linear.
Methods: Fourteen highly endurance trained subjects (12 males, 2 females) completed a ramp incremental cycling protocol, as well as 8 different constant load trials at 43 to 148 % of their critical power (CP).
BMC Pediatr
September 2025
Pediatrics Department, King Fahad Military Medical Complex, Dhahran, Saudi Arabia.
Background: Acute splenic sequestration crisis (ASSC) is a potentially life-threatening complication of sickle cell disease (SCD). Previous studies have shown that patients who carry the African sickle gene haplotypes have more severe SCD than those with the Asian haplotype. In Saudi Arabia (SA), people living in the eastern region are known to carry the Asian haplotype, whereas patients in the southwestern (SW) region are more likely to carry the African haplotype.
View Article and Find Full Text PDFBMC Nephrol
August 2025
Department of Medical Diagnostics, Faculty of Allied Health Sciences, College of Health Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Background: Neutrophil gelatinase-associated lipocalin (NGAL) is present in secondary granules of neutrophils and it is a relatively newly recognized marker of kidney diseases. The fibrinogen-to-albumin ratio (FAR) is a marker of inflammation but its diagnostic value has not been determined in sickle cell disease patients with kidney diseases. This study investigated the diagnostic roles of serum neutrophil gelatinase-associated lipocalin (sNGAL) and FAR for kidney diseases in steady-state adult sickle cell disease (SCD) patients.
View Article and Find Full Text PDF